Patrick Amstutz
Founder en MOLECULAR PARTNERS AG .
Fortuna: 3 M $ al 31/03/2024
Perfil
Patrick Amstutz is the founder of Molecular Partners AG, a company founded in 2004, where he holds the title of Chief Executive Officer & Director.
He is currently the Chief Executive Officer & Director at Molecular Partners, Inc. and the President at Swiss Biotech Association since 2017.
Dr. Amstutz has a doctorate degree from the University of Zurich and a graduate degree from the Swiss Federal Institute of Technology.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
MOLECULAR PARTNERS AG
2.02% | 31/12/2023 | 735 095 ( 2.02% ) | 3 M $ | 31/03/2024 |
Cargos activos de Patrick Amstutz
Empresas | Cargo | Inicio |
---|---|---|
MOLECULAR PARTNERS AG | Founder | 23/11/2004 |
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | President | 03/05/2022 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Chief Executive Officer | - |
Formación de Patrick Amstutz.
University of Zurich | Doctorate Degree |
Swiss Federal Institute of Technology | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
MOLECULAR PARTNERS AG | Health Technology |
Empresas privadas | 2 |
---|---|
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | Commercial Services |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Health Technology |
- Bolsa de valores
- Insiders
- Patrick Amstutz